Nektar Therapeutics (NKTR) Q2 2025 Earnings

May 8Confirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-3.6
-2.39
-1.18
0.03

Details

Expected EPS
-2.56425
Actual EPS
-3.6
Surprise EPS
-1.04
Surprise Percent
-40.39%

Description

⁨Nektar Therapeutics⁩ (⁦NKTR⁩) has reported earnings of ⁦-3.6⁩ per share for ⁦Q2 2025⁩.

0 Comments

Share your thoughts